211 related articles for article (PubMed ID: 26319061)
1. Persistence of measles antibodies, following changes in the recommended age for the second dose of MMR-vaccine in Portugal.
Gonçalves G; Frade J; Nunes C; Mesquita JR; Nascimento MS
Vaccine; 2015 Sep; 33(39):5057-63. PubMed ID: 26319061
[TBL] [Abstract][Full Text] [Related]
2. Persistence of rubella and mumps antibodies, following changes in the recommended age for the second dose of MMR vaccine in Portugal.
Gonçalves G; Frade J; Nascimento MS; Mesquita JR; Nunes C
Epidemiol Infect; 2016 Nov; 144(15):3139-3147. PubMed ID: 27488930
[TBL] [Abstract][Full Text] [Related]
3. Detection of serum antibodies against measles, mumps and rubella after primary measles, mumps and rubella (MMR) vaccination in children.
Rafiei Tabatabaei S; Esteghamati AR; Shiva F; Fallah F; Radmanesh R; Abdinia B; Shamshiri AR; Khairkhah M; Shekari Ebrahimabad H; Karimi A
Arch Iran Med; 2013 Jan; 16(1):38-41. PubMed ID: 23273235
[TBL] [Abstract][Full Text] [Related]
4. [Antibody persistence following on different vaccination strategies of domestic measles, mumps and rubella combined attenuated live vaccine: a 3-year follow-up study].
He HQ; Li Q; Yan R; Zhou Y; Tang XW; Deng X; Xie SY; Chen ZP
Zhonghua Yu Fang Yi Xue Za Zhi; 2017 Apr; 51(4):336-340. PubMed ID: 28395468
[No Abstract] [Full Text] [Related]
5. [A seroconversion study of the measles component of the MMR vaccine in adolescents of the town of Sabrosa].
Gonçalves G; Tavares F; de Andrade HR
Acta Med Port; 1998 Dec; 11(12):1079-84. PubMed ID: 10192981
[TBL] [Abstract][Full Text] [Related]
6. Similar Antibody Levels in 3-Year-Old Children Vaccinated Against Measles, Mumps, and Rubella at the Age of 12 Months or 18 Months.
Kontio M; Palmu AA; Syrjänen RK; Lahdenkari M; Ruokokoski E; Davidkin I; Vaarala O; Melin M
J Infect Dis; 2016 Jun; 213(12):2005-13. PubMed ID: 26908733
[TBL] [Abstract][Full Text] [Related]
7. Humoral and cellular immune response after measles vaccination in Taiwan.
Huang CL; Yang YH; Wang LC; Lin YT; Tsai YY; Chiang BL
J Microbiol Immunol Infect; 2005 Jun; 38(3):169-75. PubMed ID: 15986066
[TBL] [Abstract][Full Text] [Related]
8. Measles-mumps-rubella revaccination; 18 months vs. 4-6 years of age: potential impacts of schedule changes.
Saffar MJ; Fathpour GR; Parsaei MR; Ajami A; Khalilian AR; Shojaei J; Saffar H
J Trop Pediatr; 2011 Oct; 57(5):347-51. PubMed ID: 21078605
[TBL] [Abstract][Full Text] [Related]
9. Persistence of measles, mumps, and rubella antibodies in an MMR-vaccinated cohort: a 20-year follow-up.
Davidkin I; Jokinen S; Broman M; Leinikki P; Peltola H
J Infect Dis; 2008 Apr; 197(7):950-6. PubMed ID: 18419470
[TBL] [Abstract][Full Text] [Related]
10. Immunogenicity and safety assessments after one and two doses of a refrigerator-stable tetravalent measles-mumps-rubella-varicella vaccine in healthy children during the second year of life.
Schuster V; Otto W; Maurer L; Tcherepnine P; Pfletschinger U; Kindler K; Soemantri P; Walther U; Macholdt U; Douha M; Pierson P; Willems P
Pediatr Infect Dis J; 2008 Aug; 27(8):724-30. PubMed ID: 18600190
[TBL] [Abstract][Full Text] [Related]
11. Antibodies to measles, mumps, and rubella virus in Thai children after two-dose vaccination at 9 months and 2.5 years: A longitudinal study.
Wanlapakorn N; Puenpa J; Thongmee T; Srimuan D; Thatsanathorn T; Vongpunsawad S; Poovorawan Y
Vaccine; 2020 May; 38(24):4016-4023. PubMed ID: 32331806
[TBL] [Abstract][Full Text] [Related]
12. Persistence of antibodies induced by measles-mumps-rubella vaccine in children in India.
Raut SK; Kulkarni PS; Phadke MA; Jadhav SS; Kapre SV; Dhere RM; Dhorje SP; Godse SR
Clin Vaccine Immunol; 2007 Oct; 14(10):1370-1. PubMed ID: 17699834
[TBL] [Abstract][Full Text] [Related]
13. Measles, mumps, and rubella antibody patterns of persistence and rate of decline following the second dose of the MMR vaccine.
Seagle EE; Bednarczyk RA; Hill T; Fiebelkorn AP; Hickman CJ; Icenogle JP; Belongia EA; McLean HQ
Vaccine; 2018 Feb; 36(6):818-826. PubMed ID: 29317117
[TBL] [Abstract][Full Text] [Related]
14. [Age-related seroprevalence of measles, mumps and rubella antibodies in 1996].
Zäch K; Nicoara C; Germann D; Matter L
Schweiz Med Wochenschr; 1998 Apr; 128(17):649-57. PubMed ID: 9622837
[TBL] [Abstract][Full Text] [Related]
15. Two-year antibody persistence in children vaccinated at 12-15 months with a measles-mumps-rubella virus vaccine without human serum albumin.
Berry AA; Abu-Elyazeed R; Diaz-Perez C; Mufson MA; Harrison CJ; Leonardi M; Twiggs JD; Peltier C; Grogg S; Carbayo A; Shapiro S; Povey M; Baccarini C; Innis BL; Henry O
Hum Vaccin Immunother; 2017 Jul; 13(7):1516-1522. PubMed ID: 28481690
[TBL] [Abstract][Full Text] [Related]
16. Susceptibility to measles, mumps, and rubella in 5-year-old children in Flanders, Belgium.
Leuridan E; Maertens K; Wautier M; Hutse V; Theeten H
Eur J Pediatr; 2015 Jul; 174(7):925-32. PubMed ID: 25579232
[TBL] [Abstract][Full Text] [Related]
17. Immunogenicity of second dose measles-mumps-rubella (MMR) vaccine and implications for serosurveillance.
Pebody RG; Gay NJ; Hesketh LM; Vyse A; Morgan-Capner P; Brown DW; Litton P; Miller E
Vaccine; 2002 Jan; 20(7-8):1134-40. PubMed ID: 11803074
[TBL] [Abstract][Full Text] [Related]
18. Similar immunogenicity of measles-mumps-rubella (MMR) vaccine administrated at 8 months versus 12 months age in children.
He H; Chen E; Chen H; Wang Z; Li Q; Yan R; Guo J; Zhou Y; Pan J; Xie S
Vaccine; 2014 Jun; 32(31):4001-5. PubMed ID: 24837773
[TBL] [Abstract][Full Text] [Related]
19. Measles and rubella serosusceptibity among population vaccinated with different schedules: the potential impact on measles-rubella elimination in Iran.
Saffar H; Khalifeloo M; Saffar MJ; Abdollahi A; Parsaei MR; Ghorbani GR; Salarvand S; Aarabi M
BMC Infect Dis; 2021 Mar; 21(1):305. PubMed ID: 33765968
[TBL] [Abstract][Full Text] [Related]
20. Waning immunity of one-dose measles-mumps-rubella vaccine to mumps in children from kindergarten to early school age: a prospective study.
Liu Y; Liu Z; Deng X; Hu Y; Wang Z; Lu P; Guo H; Sun X; Xu Y; Tang F; Zhu FC
Expert Rev Vaccines; 2018 May; 17(5):445-452. PubMed ID: 29478347
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]